Cargando…

The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study

BACKGROUND: North Sea Progressive Myoclonus Epilepsy is a rare and severe disorder caused by mutations in the GOSR2 gene. It is clinically characterized by progressive myoclonus, seizures, early-onset ataxia and areflexia. As in other progressive myoclonus epilepsies, the efficacy of antiepileptic d...

Descripción completa

Detalles Bibliográficos
Autores principales: van Egmond, Martje E., Weijenberg, Amerins, van Rijn, Margreet E., Elting, Jan Willem J., Gelauff, Jeannette M., Zutt, Rodi, Sival, Deborah A., Lambrechts, Roald A., Tijssen, Marina A. J., Brouwer, Oebele F., de Koning, Tom J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340041/
https://www.ncbi.nlm.nih.gov/pubmed/28264719
http://dx.doi.org/10.1186/s13023-017-0595-3
_version_ 1782512772836229120
author van Egmond, Martje E.
Weijenberg, Amerins
van Rijn, Margreet E.
Elting, Jan Willem J.
Gelauff, Jeannette M.
Zutt, Rodi
Sival, Deborah A.
Lambrechts, Roald A.
Tijssen, Marina A. J.
Brouwer, Oebele F.
de Koning, Tom J.
author_facet van Egmond, Martje E.
Weijenberg, Amerins
van Rijn, Margreet E.
Elting, Jan Willem J.
Gelauff, Jeannette M.
Zutt, Rodi
Sival, Deborah A.
Lambrechts, Roald A.
Tijssen, Marina A. J.
Brouwer, Oebele F.
de Koning, Tom J.
author_sort van Egmond, Martje E.
collection PubMed
description BACKGROUND: North Sea Progressive Myoclonus Epilepsy is a rare and severe disorder caused by mutations in the GOSR2 gene. It is clinically characterized by progressive myoclonus, seizures, early-onset ataxia and areflexia. As in other progressive myoclonus epilepsies, the efficacy of antiepileptic drugs is disappointingly limited in North Sea Progressive Myoclonus Epilepsy. The ketogenic diet and the less restrictive modified Atkins diet have been proven to be effective in other drug-resistant epilepsy syndromes, including those with myoclonic seizures. Our aim was to evaluate the efficacy of the modified Atkins diet in patients with North Sea Progressive Myoclonus Epilepsy. RESULTS: Four North Sea Progressive Myoclonus Epilepsy patients (aged 7–20 years) participated in an observational, prospective, open-label study on the efficacy of the modified Atkins diet. Several clinical parameters were assessed at baseline and again after participants had been on the diet for 3 months. The primary outcome measure was health-related quality of life, with seizure frequency and blinded rated myoclonus severity as secondary outcome measures. Ketosis was achieved within 2 weeks and all patients completed the 3 months on the modified Atkins diet. The diet was well tolerated by all four patients. Health-related quality of life improved considerably in one patient and showed sustained improvement during long-term follow-up, despite the progressive nature of the disorder. Health-related quality of life remained broadly unchanged in the other three patients and they did not continue the diet. Seizure frequency remained stable and blinded rating of their myoclonus showed improvement, albeit modest, in all patients. CONCLUSIONS: This observational, prospective study shows that some North Sea Progressive Myoclonus Epilepsy patients may benefit from the modified Atkins diet with sustained health-related quality of life improvement. Not all our patients continued on the diet, but nonetheless we show that the modified Atkins diet might be considered as a possible treatment in this devastating disorder.
format Online
Article
Text
id pubmed-5340041
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53400412017-03-10 The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study van Egmond, Martje E. Weijenberg, Amerins van Rijn, Margreet E. Elting, Jan Willem J. Gelauff, Jeannette M. Zutt, Rodi Sival, Deborah A. Lambrechts, Roald A. Tijssen, Marina A. J. Brouwer, Oebele F. de Koning, Tom J. Orphanet J Rare Dis Research BACKGROUND: North Sea Progressive Myoclonus Epilepsy is a rare and severe disorder caused by mutations in the GOSR2 gene. It is clinically characterized by progressive myoclonus, seizures, early-onset ataxia and areflexia. As in other progressive myoclonus epilepsies, the efficacy of antiepileptic drugs is disappointingly limited in North Sea Progressive Myoclonus Epilepsy. The ketogenic diet and the less restrictive modified Atkins diet have been proven to be effective in other drug-resistant epilepsy syndromes, including those with myoclonic seizures. Our aim was to evaluate the efficacy of the modified Atkins diet in patients with North Sea Progressive Myoclonus Epilepsy. RESULTS: Four North Sea Progressive Myoclonus Epilepsy patients (aged 7–20 years) participated in an observational, prospective, open-label study on the efficacy of the modified Atkins diet. Several clinical parameters were assessed at baseline and again after participants had been on the diet for 3 months. The primary outcome measure was health-related quality of life, with seizure frequency and blinded rated myoclonus severity as secondary outcome measures. Ketosis was achieved within 2 weeks and all patients completed the 3 months on the modified Atkins diet. The diet was well tolerated by all four patients. Health-related quality of life improved considerably in one patient and showed sustained improvement during long-term follow-up, despite the progressive nature of the disorder. Health-related quality of life remained broadly unchanged in the other three patients and they did not continue the diet. Seizure frequency remained stable and blinded rating of their myoclonus showed improvement, albeit modest, in all patients. CONCLUSIONS: This observational, prospective study shows that some North Sea Progressive Myoclonus Epilepsy patients may benefit from the modified Atkins diet with sustained health-related quality of life improvement. Not all our patients continued on the diet, but nonetheless we show that the modified Atkins diet might be considered as a possible treatment in this devastating disorder. BioMed Central 2017-03-07 /pmc/articles/PMC5340041/ /pubmed/28264719 http://dx.doi.org/10.1186/s13023-017-0595-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
van Egmond, Martje E.
Weijenberg, Amerins
van Rijn, Margreet E.
Elting, Jan Willem J.
Gelauff, Jeannette M.
Zutt, Rodi
Sival, Deborah A.
Lambrechts, Roald A.
Tijssen, Marina A. J.
Brouwer, Oebele F.
de Koning, Tom J.
The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study
title The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study
title_full The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study
title_fullStr The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study
title_full_unstemmed The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study
title_short The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study
title_sort efficacy of the modified atkins diet in north sea progressive myoclonus epilepsy: an observational prospective open-label study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340041/
https://www.ncbi.nlm.nih.gov/pubmed/28264719
http://dx.doi.org/10.1186/s13023-017-0595-3
work_keys_str_mv AT vanegmondmartjee theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT weijenbergamerins theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT vanrijnmargreete theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT eltingjanwillemj theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT gelauffjeannettem theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT zuttrodi theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT sivaldeboraha theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT lambrechtsroalda theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT tijssenmarinaaj theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT brouweroebelef theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT dekoningtomj theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT vanegmondmartjee efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT weijenbergamerins efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT vanrijnmargreete efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT eltingjanwillemj efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT gelauffjeannettem efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT zuttrodi efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT sivaldeboraha efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT lambrechtsroalda efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT tijssenmarinaaj efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT brouweroebelef efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy
AT dekoningtomj efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy